![Mark Mallon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Mallon
Amministratore Delegato presso
George Medicines UK Ltd.
Profilo
Mark Mallon è un amministratore delegato e direttore di NeoGenomics Laboratories, Inc. e un amministratore delegato e direttore di NeoGenomics, Inc. Fa parte del Consiglio di amministrazione di NeoGenomics Laboratories, Inc. e NeoGenomics, Inc. Mallon è stato precedentemente impiegato come amministratore delegato e direttore di Ironwood Pharmaceuticals, Inc., presidente di Astrazeneca China Ltd., direttore operativo di Astrazeneca Japan Ltd., vicepresidente di Marketing & Sales Operations di AstraZeneca Pharmaceuticals LP e vicepresidente esecutivo internazionale di AstraZeneca Plc. È stato anche membro del consiglio di amministrazione di Christiana Care Corp. Si è laureato presso l'Università della Pennsylvania e ha conseguito un MBA presso la Wharton School dell'Università della Pennsylvania.
Posizioni attive di Mark Mallon
| Società | Posizione | Inizio |
|---|---|---|
George Medicines UK Ltd.
 George Medicines UK Ltd. BiotechnologyHealth Technology Develops and commercializes drugs | Amministratore Delegato | 15/04/2024 |
Precedenti posizioni note di Mark Mallon
| Società | Posizione | Fine |
|---|---|---|
| NEOGENOMICS, INC. | Amministratore Delegato | 28/03/2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Amministratore Delegato | 12/03/2021 |
Astrazeneca China Ltd. | Presidente | 01/11/2011 |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Direttore operativo | 01/04/2011 |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Presidente | - |
Formazione di Mark Mallon
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Health Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astrazeneca China Ltd. | |
Christiana Care Corp.
 Christiana Care Corp. Hospital/Nursing ManagementHealth Services Operates as a health care organizations | Health Services |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology Develops and commercializes drugs | Health Technology |
